Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging

Pharmaceutical Research

Volumn 27, Issue 7, 2010, Pages 1408-1415

  Kweon, Soonjae ^a   Lee, Ho Joon ^b   Hyung, Woo Jin ^b   Suh, Jinsuk ^b   Lim, Joon Seok ^b   Lim, Soo Jeong ^a  

^a Sejong University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Computed tomography; Contrast agent; Iopamidol; Lipiodol; Liposome

Indexed keywords

IODINATED POPPYSEED OIL; IODINE; IOPAMIDOL; LIPOSOME; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; DISPERSION; DRUG DETERMINATION; DRUG MIXTURE; DRUG SOLUBILITY; DRUG SYNTHESIS; EVAPORATION; FEMALE; LIPOSOMAL DELIVERY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; TARGET ORGAN; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; MONONUCLEAR PHAGOCYTE; PROCEDURES;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FEMALE; IODIZED OIL; IOPAMIDOL; LIPOSOMES; MONONUCLEAR PHAGOCYTE SYSTEM; RATS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953615786     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0135-5     Document Type: Article

References (25)

1. MT Krauze J Forsayeth JW Park KS Bankiewicz 2006 Real-time imaging and quantification of brain delivery of liposomes Pharm Res 23 2493 2504 10.1007/s11095-006-9103-5 1:CAS:528:DC%2BD28XhtFKgu7nF 16972184 (Pubitemid 44691597)
2. J Garbino A Adam 2006 Use of high-dose liposomal amphotericin B: efficacy and tolerance Acta Biomed 19 22 19 22
3. A Rutten M Prokop 2007 Contrast agents in X-ray computed tomography and its applications in oncology Anticancer Agents Med Chem 7 307 316 10.2174/187152007780618162 1:CAS:528:DC%2BD2sXksVWhurw%3D 17504157
4. HJ Jang H Yu TK Kim 2009 Imaging of focal liver lesions Semin Roentgenol 44 266 282 10.1053/j.ro.2009.05.008 19715792
5. PJ Ryan MA Davis LR DeGaeta B Woda DL Melchior 1984 Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress Radiology 152 759 762 1:CAS:528:DyaL2cXmtVKrtrw%3D 6611564
6. SE Seltzer M Blau LW Herman RL Hooshmand LA Herman DF Adams, et al. 1995 Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics Radiology 194 775 781 1:STN:280:DyaK2M7mslWhtw%3D%3D 7862978
7. W Krause J Leike A Sachse G Schuhmann-Giampieri 1993 Characterization of iopromide liposomes Invest Radiol 28 1028 1032 10.1097/00004424-199311000-00011 1:CAS:528:DyaK2cXhsFOltrg%3D 8276573
8. J Petersein B Franke X Fouillet B Hamm 1999 Evaluation of liposomal contrast agents for liver CT in healthy rabbits Invest Radiol 34 401 409 10.1097/00004424-199906000-00003 1:CAS:528:DyaK1MXjslOmt74%3D 10353032 (Pubitemid 29239356)
9. S Mukundan Jr KB Ghaghada CT Badea CY Kao LW Hedlund JM Provenzale, et al. 2006 A liposomal nanoscale contrast agent for preclinical CT in mice AJR Am J Roentgenol 186 300 307 10.2214/AJR.05.0523 16423931 (Pubitemid 46100296)
10. JT Kim SH Heo SM Choi SH Lee MS Park BC Kim, et al. 2009 Cerebral embolism of iodized oil (lipiodol) after transcatheter arterial chemoembolization for hepatocellular carcinoma J Neuroimaging 19 394 397 10.1111/j.1552-6569.2009.00380.x 19496902
11. S Kohnoe I Takahashi H Kawanaka M Mori K Okadome K Sugimachi 1993 Combination of preoperative lymphangiography using lipiodol and intraoperative lymphangiography using Evans Blue facilitates the accurate identification of postoperative chylous fistulas Surg Today 23 929 931 10.1007/BF00311375 1:STN:280:DyaK2c7ivFWnsg%3D%3D 8298240
12. F Nacka M Cansell P Meleard N Combe 2001 Incorporation of alpha-tocopherol in marine lipid-based liposomes: in vitro and in vivo studies Lipids 36 1313 1320 10.1007/s11745-001-0846-x 1:CAS:528:DC%2BD38Xosl2quw%3D%3D 11834082
13. F Szoka Jr D Papahadjopoulos 1978 Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation Proc Natl Acad Sci USA 75 4194 4198 10.1073/pnas.75.9.4194 1:CAS:528: DyaE1MXhvVOhsA%3D%3D 279908
14. SJ Lim CK Kim 2002 Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid Int J Pharm 243 135 146 10.1016/S0378-5173(02)00269-7 1:CAS:528: DC%2BD38Xmt1ygtLc%3D 12176302
15. JLM Stewart 1959 Colorimetric determination of phospholipids with ammonium ferrothiocyanate Anal Biochem 104 10 14 10.1016/0003-2697(80)90269-9
16. TM Allen L McAllister S Mausolf E Gyorffy 1981 Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines Biochim Biophys Acta 643 346 362 10.1016/0005-2736(81)90080-8 1:CAS:528:DyaL3MXktlSgtrw%3D 7225387
17. TS Desser DL Rubin H Muller GL McIntire ER Bacon JL Toner 1999 Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol Acad Radiol 6 176 183 10.1016/S1076-6332(99)80404-8 1:STN:280: DC%2BD3czlsVCjsA%3D%3D 10898037
18. A Sachse JU Leike GL Rossling SE Wagner W Krause 1993 Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection Invest Radiol 28 838 844 1:CAS:528:DyaK2cXhsFOltb4%3D 8225891
19. J Leike A Sachse C Ehritt 1996 Biodistribution and CT-imaging characteristics of iopromide-carrying liposomes in rats J Liposome Res 6 665 680 10.3109/08982109609039920 1:CAS:528:DyaK28XnsFOrtbs%3D
20. SE Seltzer MA Davis DF Adams PM Shulkin WJ Landis A Havron 1984 Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications Invest Radiol 19 142 151 10.1097/00004424-198403000-00012 1:CAS:528:DyaL2cXitVGrsLg%3D 6533105
21. SK Sharma 2008 Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent? J Invasive Cardiol 20 245 248 18460711
22. A Sachse JU Leike T Schneider SE Wagner GL Rossling W Krause, et al. 1997 Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes Invest Radiol 32 44 50 10.1097/00004424-199701000-00007 1:CAS:528:DyaK2sXoslKluw%3D%3D 9007647 (Pubitemid 27034546)
23. WH Kong WJ Lee ZY Cui KH Bae TG Park JH Kim, et al. 2007 Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging Biomaterials 28 5555 5561 10.1016/j.biomaterials.2007.08.044 1:CAS:528:DC%2BD2sXht1WqtbfN 17904632 (Pubitemid 47599640)
24. M Bourin P Jolliet F Ballereau 1997 An overview of the clinical pharmacokinetics of x-ray contrast media Clin Pharmacokinet 32 180 193 10.2165/00003088-199732030-00002 1:CAS:528:DyaK2sXisV2ks70%3D 9084958
25. RJ Solomon R Mehran MK Natarajan S Doucet RE Katholi CS Staniloae, et al. 2009 Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 4 1162 1169 10.2215/CJN.00550109 19556381